Study drug And NotU. Liberman
List of bibliographic references
Number of relevant bibliographic references: 4.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000E51 | Joachim Sieper [Allemagne] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Philip J. Mease [États-Unis] ; Walter P. Maksymowych [Canada] ; Matthew A. Brown [Australie] ; Vipin Arora [États-Unis] ; Aileen L. Pangan [États-Unis] | Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) |
| 000E73 | J. Yale [Canada] ; G. Bakris [États-Unis] ; B. Cariou [France] ; D. Yue [Australie] ; E. David-Neto [Brésil] ; L. Xi [États-Unis] ; K. Figueroa [États-Unis] ; E. Wajs [Belgique] ; K. Usiskin [États-Unis] ; G. Meininger [États-Unis] | Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease |
| 001853 | D. F. Murrell [Australie] ; S. Calvieri [Italie] ; J. P. Ortonne [France] ; V. C. Ho [Canada] ; S. Weise-Riccardi [Suisse] ; N. Barbier [Suisse] ; C. F. Paul [France] | A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids |
| 001A90 | L B A. Van De Putte [Pays-Bas] ; C. Atkins [Canada] ; M. Malaise [Belgique] ; J. Sany [France] ; A S Russell [Canada] ; P L C M. Van Riel [Pays-Bas] ; L. Settas [Grèce] ; J W Bijlsma [Pays-Bas] ; S. Todesco [Italie] ; M. Dougados [France] ; P. Nash [Australie] ; P. Emery [Royaume-Uni] ; N. Walter [Allemagne] ; M. Kaul [Allemagne] ; S. Fischkoff [États-Unis] ; H. Kupper [Allemagne] | Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed |
| This area was generated with Dilib version V0.6.33. |  |